{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T19:26:34Z","timestamp":1776972394093,"version":"3.51.4"},"reference-count":69,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T00:00:00Z","timestamp":1565049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002997","name":"Nierstichting","doi-asserted-by":"publisher","award":["Grant E.033"],"award-info":[{"award-number":["Grant E.033"]}],"id":[{"id":"10.13039\/501100002997","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Hartstichting","doi-asserted-by":"publisher","award":["Grant 2001-005"],"award-info":[{"award-number":["Grant 2001-005"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005075","name":"Universitair Medisch Centrum Groningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005075","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Dade Behring, Ausam, Roche, and Abbott"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0220659","type":"journal-article","created":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T17:26:40Z","timestamp":1565112400000},"page":"e0220659","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Plasma ApoE elevations are associated with NAFLD: The PREVEND Study"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2703-2320","authenticated-orcid":true,"given":"Eline H.","family":"van den Berg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James P.","family":"Corsetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan J. L.","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin P. F.","family":"Dullaart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,8,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nrgastro.2013.171","article-title":"The global NAFLD epidemic","volume":"10","author":"R Loomba","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol. Nature Publishing Group"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"715","DOI":"10.4254\/wjh.v9.i16.715","article-title":"Non-alcoholic fatty liver disease: An expanded review","volume":"9","author":"M Benedict","year":"2017","journal-title":"World J Hepatol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2017.06.024","article-title":"Liver steatosis: The new epidemic of the Third Millennium. Benign liver state or silent killer?","volume":"46","author":"C Puoti","year":"2017","journal-title":"Eur J Intern Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/hep.20920","article-title":"Insulin resistance: a metabolic pathway to chronic liver disease","volume":"42","author":"E Bugianesi","year":"2005","journal-title":"Hepatology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/jgh.13264","article-title":"Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis","volume":"31","author":"S Ballestri","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1210\/jc.2015-3111","article-title":"Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD","volume":"101","author":"F Bril","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.metabol.2017.04.004","article-title":"High prevalence of apolipoprotein B dyslipoproteinemias in non-alcoholic fatty liver disease: The lifelines cohort study","volume":"72","author":"KJ Nass","year":"2017","journal-title":"Metab Clin Exp"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e0171502","DOI":"10.1371\/journal.pone.0171502","article-title":"Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort","volume":"12","author":"EH van den Berg","year":"2017","journal-title":"PLoS ONE"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.3748\/wjg.v13.i10.1579","article-title":"Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease","volume":"13","author":"M Hamaguchi","year":"2007","journal-title":"World J Gastroenterol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.cca.2017.01.008","article-title":"Associations of the fatty liver and hepatic steatosis indices with risk of cardiovascular disease: Interrelationship with age","volume":"466","author":"SK Kunutsor","year":"2017","journal-title":"Clin Chim Acta"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00125-005-0125-z","article-title":"Overproduction of large VLDL particles is driven by increased liver fat content in man","volume":"49","author":"M Adiels","year":"2006","journal-title":"Diabetologia"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1053\/j.gastro.2007.11.038","article-title":"Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease","volume":"134","author":"E Fabbrini","year":"2008","journal-title":"Gastroenterology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.2337\/dc07-1088","article-title":"Intrahepatic fat accumulation and alterations in lipoprotein composition in obese adolescents: a perfect proatherogenic state","volume":"30","author":"AMG Cali","year":"2007","journal-title":"Diabetes Care"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/liv.13076","article-title":"Steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease","volume":"36","author":"ZG Jiang","year":"2016","journal-title":"Liver Int"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1016\/S0021-9258(18)34702-1","article-title":"Human apolipoprotein E. The complete amino acid sequence","volume":"257","author":"SC Rall","year":"1982","journal-title":"J Biol Chem"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0009-8981(99)00097-2","article-title":"Apolipoprotein E and atherosclerosis: insight from animal and human studies","volume":"286","author":"J Davignon","year":"1999","journal-title":"Clin Chim Acta"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00109-004-0631-3","article-title":"The key role of apolipoprotein E in atherosclerosis","volume":"83","author":"K Greenow","year":"2005","journal-title":"J Mol Med"},{"issue":"Suppl","key":"ref18","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.1194\/jlr.R800069-JLR200","article-title":"Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer&apos;s disease to AIDS","volume":"50","author":"RW Mahley","year":"2009","journal-title":"J Lipid Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0021-9150(97)00053-1","article-title":"Distribution of apolipoprotein E between apo B- and non apo B-containing lipoproteins according to apo E phenotype","volume":"131","author":"G Luc","year":"1997","journal-title":"Atherosclerosis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.tibs.2006.06.008","article-title":"Apolipoprotein E structure: insights into function","volume":"31","author":"DM Hatters","year":"2006","journal-title":"Trends Biochem Sci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00041433-200006000-00004","article-title":"Apolipoprotein E and atherosclerosis","volume":"11","author":"LK Curtiss","year":"2000","journal-title":"Curr Opin Lipidol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/mnfr.200700322","article-title":"Impact of apoE genotype on oxidative stress, inflammation and disease risk","volume":"52","author":"L Jofre-Monseny","year":"2008","journal-title":"Mol Nutr Food Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"26388","DOI":"10.1074\/jbc.273.41.26388","article-title":"Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia","volume":"273","author":"Y Huang","year":"1998","journal-title":"J Biol Chem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S0022-2275(20)32379-8","article-title":"Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects","volume":"41","author":"R Batal","year":"2000","journal-title":"J Lipid Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1161\/01.ATV.16.1.149","article-title":"Plasma concentration of apolipoprotein E in intermediate-sized remnant-like lipoproteins in normolipidemic and hyperlipidemic subjects","volume":"16","author":"JS Cohn","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.atherosclerosis.2013.06.019","article-title":"The positive relationship of serum paraoxonase-1 activity with apolipoprotein E is abrogated in metabolic syndrome","volume":"230","author":"RPF Dullaart","year":"2013","journal-title":"Atherosclerosis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.metabol.2010.01.015","article-title":"Increased apolipoprotein E level and reduced high-density lipoprotein mean particle size associate with low high-density lipoprotein cholesterol and features of metabolic syndrome","volume":"59","author":"S S\u00f6derlund","year":"2010","journal-title":"Metab Clin Exp"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jacl.2016.03.003","article-title":"Apolipoprotein E levels and apolipoprotein E genotypes in incident cardiovascular disease risk in subjects of the Prevention of Renal and Vascular End-stage disease study","volume":"10","author":"JP Corsetti","year":"2016","journal-title":"J Clin Lipidol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.metabol.2011.11.010","article-title":"Apolipoprotein E predicts incident cardiovascular disease risk in women but not in men with concurrently high levels of high-density lipoprotein cholesterol and C-reactive protein","volume":"61","author":"JP Corsetti","year":"2012","journal-title":"Metab Clin Exp"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e39110","DOI":"10.1371\/journal.pone.0039110","article-title":"Apolipoprotein A-II influences apolipoprotein E-linked cardiovascular disease risk in women with high levels of HDL cholesterol and C-reactive protein","volume":"7","author":"JP Corsetti","year":"2012","journal-title":"PLoS ONE"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/BF00291670","article-title":"A physical map of the apolipoprotein gene cluster on human chromosome 19","volume":"78","author":"O Myklebost","year":"1988","journal-title":"Hum Genet"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1006\/geno.1995.1144","article-title":"Identification and characterization of a new human gene (APOC4) in the apolipoprotein E, C-I, and C-II gene locus","volume":"28","author":"CM Allan","year":"1995","journal-title":"Genomics"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF01790099","article-title":"Apolipoprotein E polymorphism in The Netherlands and its effect on plasma lipid and apolipoprotein levels","volume":"80","author":"M Smit","year":"1988","journal-title":"Hum Genet"},{"key":"ref34","first-page":"104","article-title":"Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism","volume":"42","author":"E Boerwinkle","year":"1988","journal-title":"Am J Hum Genet"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1001\/jama.298.11.1300","article-title":"Association of apolipoprotein E genotypes with lipid levels and coronary risk","volume":"298","author":"AM Bennet","year":"2007","journal-title":"JAMA"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1111\/j.1742-4658.2011.08238.x","article-title":"Deficiency in apolipoprotein E has a protective effect on diet-induced nonalcoholic fatty liver disease in mice","volume":"278","author":"EA Karavia","year":"2011","journal-title":"FEBS J"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"12931","DOI":"10.1038\/srep12931","article-title":"Seven weeks of Western diet in apolipoprotein-E-deficient mice induce metabolic syndrome and non-alcoholic steatohepatitis with liver fibrosis","volume":"5","author":"R Schierwagen","year":"2015","journal-title":"Sci Rep"},{"key":"ref38","first-page":"1832","article-title":"The relationship between apolipoprotein E polymorphism, lipoprotein (a) and fatty liver disease","volume":"52","author":"MH Yang","year":"2005","journal-title":"Hepatogastroenterology"},{"key":"ref39","first-page":"355","article-title":"Relation of apolipoprotein E polymorphism to clinically diagnosed fatty liver disease","volume":"8","author":"D-M Lee","year":"2002","journal-title":"Taehan Kan Hakhoe Chi"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1007\/s10620-007-9740-5","article-title":"Apolipoprotein E gene polymorphism in nonalcoholic fatty liver disease","volume":"52","author":"MD Demirag","year":"2007","journal-title":"Dig Dis Sci"},{"key":"ref41","first-page":"711","article-title":"Apolipoprotein E4 allele is associated with substantial changes in the plasma lipids and hyaluronic acid content in patients with nonalcoholic fatty liver disease","volume":"64","author":"E Stachowska","year":"2013","journal-title":"J Physiol Pharmacol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1007\/s10620-008-0271-5","article-title":"Association of apolipoprotein E polymorphisms in patients with non-alcoholic steatohepatitis","volume":"53","author":"A Sazci","year":"2008","journal-title":"Dig Dis Sci"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.1007\/s11033-012-1570-7","article-title":"A case-control study on the effects of the apolipoprotein E genotypes in nonalcoholic fatty liver disease","volume":"39","author":"E De Feo","year":"2012","journal-title":"Mol Biol Rep"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1365-2796.2010.02323.x","article-title":"Apolipoprotein B\/A-I and total cholesterol\/high-density lipoprotein cholesterol ratios both predict cardiovascular events in the general population independently of nonlipid risk factors, albuminuria and C-reactive protein","volume":"269","author":"PJWH Kappelle","year":"2011","journal-title":"J Intern Med"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1210\/jc.2005-0182","article-title":"The effect of cholesteryl ester transfer protein -629C-&gt;A promoter polymorphism on high-density lipoprotein cholesterol is dependent on serum triglycerides","volume":"90","author":"SE Borggreve","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1194\/jlr.P088997","article-title":"Serum paraoxonase 1 activity is paradoxically maintained in nonalcoholic fatty liver disease despite low HDL cholesterol","volume":"60","author":"EH van den Berg","year":"2019","journal-title":"J Lipid Res"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"LA Inker","year":"2012","journal-title":"N Engl J Med"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-230X-6-33","article-title":"The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"G Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00125-016-3902-y","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"59","year":"2016","journal-title":"Diabetologia"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","article-title":"Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease","volume":"42","author":"J-H Lee","year":"2010","journal-title":"Dig Liver Dis"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"SM Grundy","year":"2005","journal-title":"Circulation"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/(SICI)1096-9136(1998120)15:12<1031::AID-DIA705>3.0.CO;2-6","article-title":"Apolipoprotein E genotype is a determinant of low-density lipoprotein cholesterol and of its response to a low-cholesterol diet in Type 1 diabetic patients with elevated urinary albumin excretion","volume":"15","author":"EE Blaauwwiekel","year":"1998","journal-title":"Diabet Med"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"WT Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"ref54","first-page":"718","article-title":"IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. International Federation of Clinical Chemistry and Laboratory Medicine. Part 4. Reference procedure for the measurement of catalytic concentration of alanine aminotransferase","author":"G Schumann","year":"2002","journal-title":"Clinical chemistry and laboratory medicine"},{"key":"ref55","first-page":"725","article-title":"IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. International Federation of Clinical Chemistry and Laboratory Medicine. Part 5. Reference procedure for the measurement of catalytic concentration of aspartate aminotransferase","author":"G Schumann","year":"2002","journal-title":"Clinical chemistry and laboratory medicine"},{"key":"ref56","first-page":"734","article-title":"IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. International Federation of Clinical Chemistry and Laboratory Medicine. Part 6. Reference procedure for the measurement of catalytic concentration of gamma-glutamyltransferase","author":"G Schumann","year":"2002","journal-title":"Clinical chemistry and laboratory medicine"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0168-8278(01)00249-5","article-title":"Hepatic steatosis and very low density lipoprotein secretion: the involvement of apolipoprotein E","volume":"35","author":"AR Mensenkamp","year":"2001","journal-title":"J Hepatol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev.nu.15.070195.002431","article-title":"Apolipoprotein E and the apolipoprotein E-deficient mouse","volume":"15","author":"AS Plump","year":"1995","journal-title":"Annu Rev Nutr"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"35711","DOI":"10.1074\/jbc.274.50.35711","article-title":"Apolipoprotein E participates in the regulation of very low density lipoprotein-triglyceride secretion by the liver","volume":"274","author":"AR Mensenkamp","year":"1999","journal-title":"J Biol Chem"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1172\/JCI115459","article-title":"Influence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in normolipemic subjects","volume":"88","author":"T Demant","year":"1991","journal-title":"J Clin Invest"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/S0022-2275(20)32162-3","article-title":"Apolipoprotein B signal peptide and apolipoprotein E genotypes as determinants of the hepatic secretion of VLDL apoB in obese men","volume":"39","author":"FM Riches","year":"1998","journal-title":"J Lipid Res"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1161\/01.ATV.20.7.1807","article-title":"Effects of ApoE genotype on ApoB-48 and ApoB-100 kinetics with stable isotopes in humans","volume":"20","author":"FK Welty","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"Suppl","key":"ref63","doi-asserted-by":"crossref","first-page":"S156","DOI":"10.1194\/jlr.R800058-JLR200","article-title":"Apoprotein E as a lipid transport and signaling protein in the blood, liver, and artery wall","volume":"50","author":"GS Getz","year":"2009","journal-title":"J Lipid Res"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/iub.1314","article-title":"Apolipoprotein E isoforms and lipoprotein metabolism","volume":"66","author":"MC Phillips","year":"2014","journal-title":"IUBMB Life"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.atherosclerosis.2015.12.038","article-title":"Plasma levels of apolipoprotein E and risk of ischemic heart disease in the general population","volume":"246","author":"KL Rasmussen","year":"2016","journal-title":"Atherosclerosis"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.1371\/journal.pmed.0030176","article-title":"ApoE plasma levels and risk of cardiovascular mortality in old age","volume":"3","author":"SP Mooijaart","year":"2006","journal-title":"PLoS Med"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"11843","DOI":"10.1021\/bi050862i","article-title":"High affinity, stability, and lactonase activity of serum paraoxonase PON1 anchored on HDL with ApoA-I","volume":"44","author":"L Gaidukov","year":"2005","journal-title":"Biochemistry"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.atherosclerosis.2012.05.040","article-title":"Apolipoprotein E mimetic is more effective than apolipoprotein A-I mimetic in reducing lesion formation in older female apo E null mice","volume":"224","author":"G Nayyar","year":"2012","journal-title":"Atherosclerosis"},{"key":"ref69","article-title":"Serum paraoxonase-1 activity is associated with light to moderate alcohol consumption: the PREVEND cohort study","author":"EG Gruppen","year":"2018","journal-title":"Am J Clin Nutr"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0220659","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,25]],"date-time":"2022-09-25T07:10:25Z","timestamp":1664089825000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0220659"}},"subtitle":[],"editor":[{"given":"Petter","family":"Bjornstad","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,8,6]]},"references-count":69,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,8,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0220659","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,6]]}}}